Medications

Glecaprevir and pibrentasvir aid HCV-positive kidney transplants

(HealthDay)—By treating or preventing infection, glecaprevir and pibrentasvir (G/P) regimens are promising for increasing access to the transplantation of kidneys from hepatitis C virus (HCV)-positive donors to HCV-negative ...

Diseases, Conditions, Syndromes

Russia vaccine 'passes early trial test'

Early tests of a Russian coronavirus vaccine showed encouraging results when details were published Friday, but experts said the trials were too small to prove safety and effectiveness.

page 8 from 21